TRGM — Targeted Medical Pharma Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $5.19m
- $5.26m
Annual balance sheet for Targeted Medical Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2011 December 31st | C2012 December 31st | 2013 December 31st | 2014 December 31st | 2015 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K/A | 10-Q | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 0.147 | 0.327 | 0.492 | 0.012 | 0.083 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.923 | 0.354 | 0.269 | 0.203 | 0.328 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 2.9 | 2.53 | 2.63 | 0.534 | 0.833 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.412 | 0.34 | 0.236 | 0.107 | 0.054 |
| Net Intangible Assets | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 8.98 | 10.6 | 5 | 2.5 | 2.43 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 7.48 | 12.2 | 11.3 | 12.3 | 14.7 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Liabilities | 8.37 | 12.6 | 12 | 12.5 | 15.3 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 0.607 | -2 | -7.02 | -9.97 | -12.9 |
| Total Liabilities & Shareholders' Equity | 8.98 | 10.6 | 5 | 2.5 | 2.43 |
| Total Common Shares Outstanding |